MapLight Therapeutics, Inc. (MPLT) ROE
- 2026-06-30: ROE -65.99%.
- 2026-03-31: ROE -49.89%.
- 2025-12-31: ROE -35.16%.
- 2025-09-30: ROE 37.51%.
Complete source-backed roe history.
- Available history
- 2024-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | -65.99% |
| 2026-03-31 | -49.89% |
| 2025-12-31 | -35.16% |
| 2025-09-30 | 37.51% |
| 2025-06-30 | 37.72% |
| 2025-03-31 | 37.52% |
| 2024-12-31 | 40.07% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | -35.16% |
| 2024-12-31 | 40.07% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |